Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 19/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 14/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14645825 | 0.88 | HDAC4 (0.65) | HDAC4HDAC6HDAC1 | |
| SCHEMBL18985131 | 0.87 | HDAC4 (0.64) | HDAC4HDAC6HDAC1 | |
| SCHEMBL30931870 | 0.87 | HDAC4 (0.70) | HDAC4HDAC6HDAC1 | |
| SCHEMBL22531083 | 0.87 | HDAC4 (0.70) | HDAC4HDAC6HDAC1 | |
| SCHEMBL20680769 | 0.86 | HDAC4 (0.57) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL32679148 | 0.85 | NPC1 (0.56) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL32679146 | 0.85 | NPC1 (0.56) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL21806679 | 0.84 | HDAC6 (0.58) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL29241997 | 0.84 | HDAC4 (0.60) | HDAC4HDAC6HDAC1 | |
| SCHEMBL29598891 | 0.83 | HDAC6 (0.51) | HDAC4HDAC6HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169621-A1 | OXADIAZOLES FOR USE IN CONTROLLING PHYTOPATHOGENIC FUNGI | PI INDUSTRIES LTD. (IN) | 2022-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169621-A1 | OXADIAZOLES FOR USE IN CONTROLLING PHYTOPATHOGENIC FUNGI | OXA1L, CYP51A1, CYP1A1 | HDAC4 2246/4885HDAC6 1374/4885HDAC1 725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.